(Q41457706)

30 September 2017

1 reference

title

Estrogen action in human ovarian cancer (English)

1 reference

30 September 2017

1 reference

Clinton GM

1

1 reference

PubMed ID

9134308

30 September 2017

Hua W

series ordinal

2

1 reference

30 September 2017

1 January 1997

1 reference

Critical Reviews in Oncology Hematology

30 September 2017

1 reference

30 September 2017

25

1 reference

30 September 2017

1

1 reference

30 September 2017

1-9

1 reference

30 September 2017

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Ovarian surface epithelium and human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Endocrine Factors in Common Epithelial Ovarian Cancer*

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Epithelial ovarian cancer and combination oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Risk factors for epithelial ovarian cancer in women under age 45

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Impact of contraception on gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Ovarian tumors in a cohort of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Estrogen replacement therapy and fatal ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Risk factors for ovarian cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Noncontraceptive estrogen use and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Menopause and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Incessant ovulation--a factor in ovarian neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

LHRH-receptors and LHRH-agonist treatment in ovarian cancer: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Estrogen- and androgen-responsive growth of human ovarian adenocarcinoma heterotransplanted into nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Therapeutic potential of pure antioestrogens in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The future of new pure antiestrogens in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Oestrogens, proteases and breast cancer. From cell lines to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Contrasting effects of 17 beta-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Induction of progesterone receptor with 17 beta-estradiol in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Clinical significance of cathepsin D in primary ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

c-myc amplification in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Expression of the pNR-2/pS2 protein in diverse human epithelial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

c-erbB-2 oncogene expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

A somatic BRCA1 mutation in an ovarian tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

BRCA1 mutations in primary breast and ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900216-8

7 January 2021

10.1016/S1040-8428(96)00216-8

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9134308